feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

trending

Bitcoin price struggles amid fragility

trending

Buddha relics travel from Vadodara

trending

Mrunal Thakur wedding rumours

trending

Suzlon Energy Q3 results up

trending

Savannah Guthrie pleads for mother

trending

Australia vs Netherlands warm-up

trending

RCB wins WPL match

trending

Bas de Leede admires Pandya

Home / Health / Gujarat: Weight Loss Injections Surge Over Appearance

Gujarat: Weight Loss Injections Surge Over Appearance

6 Feb

Summary

  • Disease prevention, not looks, drives weight loss in Gujarat.
  • 58% of doctors see 40% of patients overweight or obese.
  • Most consumers hesitant due to cost and side effect fears.
Gujarat: Weight Loss Injections Surge Over Appearance

In Gujarat, the focus for weight management has significantly shifted from aesthetic goals to the prevention of lifestyle diseases. Nearly half of consumers now prioritize avoiding conditions like diabetes and hypertension, surpassing appearance-related motivations. This evolving perspective is leading to a notable rise in patient interest regarding medical weight-loss injections, such as GLP-1 therapies.

Doctors across Gujarat are experiencing this change, with a substantial percentage of patients inquiring about these new treatments. While these therapies have shown success for individuals struggling with obesity and related comorbidities like diabetes and sleep apnea, experts caution they are not a universal solution. Affordability remains a significant barrier for many, with consumers willing to spend a limited amount monthly for such treatments if safety and outcomes are assured.

Despite the growing awareness and availability of biosimilars, medical weight-loss injections are prescribed cautiously. They are recommended only for patients with specific health criteria, such as a high BMI or existing major comorbidities, and always alongside diet, exercise, and medical supervision. Long-term success requires ongoing management to prevent weight regain and muscle depletion.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Nearly half of consumers in Gujarat cite the prevention of lifestyle diseases like diabetes and hypertension as their primary motivation for weight loss.
The primary concerns are high costs, fear of side effects, and a lack of clear doctor guidance, with cost being the top deterrent for most consumers.
No, these injections are prescribed cautiously to patients with a BMI of 30 or more, or 27 or more with major comorbidities, alongside other lifestyle modifications.

Read more news on

Healthside-arrowGujaratside-arrow
•

You may also like

GLP-1 Drugs: Weight Regain Risks Revealed

28 Jan • 61 reads

article image

Silent Killer: BP Rises in India's Youth

26 Jan • 78 reads

article image

Breathlessness on Stairs? It's More Than Just Tiredness

27 Jan • 49 reads

article image

New Obesity Drugs Launched in India for 2025

24 Jan • 69 reads

article image

GLP-1 Drugs: Cancer's New Foe or Friend?

17 Jan • 110 reads

article image